Publications 1999-1983
199919981997199619951994199319921991199019891987  • 1983


 

1999

  1. Bouma G, Crusius JBA, García González MA, Meijer BUGA, Hellemans HPR, Hakvoort RA, Schreuder GMTh, Kostense PJ, Meuwissen SGM, Peña AS.
    Genetic markers in clinically well defined patients with ulcerative colitis (UC)
    .
    Clin Exp Immunol
    1999;115 (2): 294-300.
  2. Bouma G, Peña AS.
    Immunologie in de medische praktijk.

    XXVI. Immunogenetica van chronische inflammatoire darmziekten. Ned Tijdschr Geneeskd 1999;143: 2414-2420. 
  3. Dijkhuizen AC, Sprenger M, Peña AS.
    Videoconferencing in a clinical setting
    .
    In
    : Clinical Symposium Crossing Borders in IBD, Barcelona, Oktober 2, 1998 (Ed.: AS Peña), Drugs of Today (Prous Science), 1999; 35 (Suppl. A): 145-148.
     

    Dijkhuizen AC, Sprenger M, Peña AS.

    Videoconferencia en un contexto clínico.

    In: Simposio Clínico Cruzando fronteras en la enfermedad inflamatoria intestinal, Barcelona, 2 de octubre de 1998 (Ed.: AS Peña), Drugs of Today (Prous Science), 1999; 35 (Suppl. 7): 155-157.

  4. Hellers G, Cortot A, Jewell D, Leijonmarck CE, Lofberg R, Malchow H, Nilsson L-G, Pallone F, Peña S, Persson T, Prantera C, Rutgeerts P, IOIBD Budesonide Study Group.
    Oral Budesonide for prevention of postsurgical recurrence in Crohn's Disease.
    Gastroenterology 1999; 116(2): 294-300.
  5. Mulder CJ, Tytgat GN, Groenland F, Peña AS.
    Combined coeliac disease and thyroid disease

    [letter] Eur JGastroenterol Hepatol 1999;11(8):939-940.
  6. Nemetz A, Köpe A, Kovács A, Fehér J, Tulassay Z, Nagy F, García González MA, Peña AS.
    Significant differences in the interleukin-1b and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease.

    Scand J Gastroenterol
    1999;34(2):175-179.
  7. Nemetz A, Nosti-Escanilla MP, Molnár T, Köpe A, Kovács A, Fehér J, Tulassay Z, Nagy F, García González MA, Peña AS.
    Interleukin-1
    b gene polymorphisms influence the course and severity of IBD.
    Immunogenetics
    1999;49(6): 527-531.
  8. Nemetz A, Peña AS.
    On the genetic contribution of osteoporosis and osteoporotic fractures

    Letter for Pekka Kannus, Mika Palvanen, Jaakko Kaprio, Jari Parkkari, and Markku Koskenvuo, 23 Dec 1999; 319; 1334-1337. Electronic letters 1999
  9. Peña AS.
    Is the cause of IBD environmental?

    In
    : Inflammatory Bowel Disease: clinical diagnosis and management (Ed.: Rampton D). London: Martin Dunitz Publishers; 1999: pages: 17-34. 
  10. Peña AS.
    HLA-antigens in IBD
    .
    In
    : Innovative Concepts in Inflammatory Bowel Disease, Falk Symposium 105, Rostock, Germany (Eds.: Emmrich J, Liebe S, Stange EF), Kluwer Academic Publishers, 1999: 20-26. 
  11. Peña AS.
    Gluten sensitivity: a many headed hydra and a Trojan horse
    .
    British Medical Journal
    , 1999; 318(7200): 1710-1711 Electronic letters 26 june 1999.
  12. Peña AS, Crusius JBA, Meuwissen SGM.
    Genetic markers in ulcerative colitis. Why are the results different?
    Eur J Gastroenterol Hepatol 1999: 11(4):405-407.
     
  13. Peña AS, Meuwissen SGM, Falke, ThJM, Cuesta MA, Hanauer SB, Rutgeerts P, Tremaine BW, Gassull MA, Cortot A, Cohen Z.
    Inflammatory bowel disease. A case presentation from Amsterdam with a panel discussion in Barcelona
    .
    In
    : Clinical Symposium Crossing Borders in IBD, Barcelona, Oktober 2, 1998 (Ed.: AS Peña), Drugs of Today (Prous Science), 1999; 35 (Suppl. A): 149-159. 
    english

    Peña AS, Meuwissen SGM, Falke ThJM, Cuesta MA, Hanauer SB, Rutgeerts P, Tremaine BW, Gassull MA, Cortot A, Cohen Z.

    Enfermedad inflamatoria intestinal. Presentación de un caso desde Amsterdam con un panel de discusión en Barcelona.

    In: Simposio Clínico Cruzando fronteras en la enfermedad inflamatoria intestinal, Barcelona, 2 de octubre de 1998 (Ed.: AS Peña), Drugs of Today (Prous Science), 1999; 35 (Suppl. 7): 159-169

    spanish 

  14. Rostami K, Mulder CJ, Werre JM, Van Beukelen FR, Kerckhaert, Crusius JBA, Peña AS, Willekens FLA, Meijer JWR.
    High prevalence of celiac disease in apparently healthy blood donors suggests a high prevalence of undiagnosed celiac disease in the Dutch population
    Scand J Gastroenterol 1999; 3: 276-279.
  15. Schrijver HM, Crusius JBA, Uitdehaag BMJ, García González MA, Kostense PJ, Polman CH, Peña AS.
    Association of IL-1b and IL-1 receptor antagonist (IL-1RN) genes with disease severity in multiple sclerosis
    .
    Neurology
    1999; 52(3): 595-599.
  16. Van de Wal Y, Kooy YMC, van Veelen P, Vader W, August SA, Drijfhout JW, Peña SA, Koning, F.
    Glutenin is involved in the gluten-driven mucosal T cell response.
      
    Eur J Immunol
    1999. 29: 3133-3139
  17. Van Doorn LJ, Figuereido C, Mégraud F, Peña AS, Midolo P, Queiroz D, Carneiro F, Vanderborght B, Pegado MGF, Sanna R, De Boer W, Schneeberger P, Correa P, Ng EKW, Atherton J, Blaser MJ, Quint WGJ.
    Geographic distribution of vacA allelic types of Helicobacter pylori
    .
    Gastroenterology
    1999; 116(4): 823-830.

     
     

1998

back to top of the page

  1. Bouma G, Poen AC, García González MA, Schreuder GMTh, Felt-Bersma RJF, Meuwissen SGM, Peña AS.
    HLA-DRB1*03, but not the TNFa-308 promoter gene polymorphism, confers protection against fistulising Crohn's disease
    .
    Immunogenetics
    1998;47(6):451-455.
  2. Dieleman LA, Palmen MJHJ, Akol H, Bloemena E, Peña AS, Meuwissen SGM.” moet worden “Dieleman LA, Palmen MJHJ, Akol H, Bloemena E, Peña AS, Meuwissen SGM, van Rees EP.
    Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.

    Clin Exp Immunol
    1998;114:385-391.
  3. García González MA, Peña AS.
    Óxido nítrico y enfermedad inflamatoria intestinal
    .
    Rev Esp Enferm Dig 1998;90(12):870-876
  4. Meuwissen SGM, Peña AS.
    Diagnosis of the first attack of colitis.

    Research and Clinical Forums
    , Wells Medical, [Medscape], 1998;20(1):67-76. 
  5. Meuwissen SGM, Bouma G, Crusius JBA, Peña AS.
    Sous-groupes cliniques et génétiques dans les maladies inflammatoires de l'intestin
    .
    In
    : Maladies inflammatoires de l'intestin (Eds.: Lémann M,  Modigliani R) Progrès en hépato-gastroentérologie, 1998;4: 59-74. 
  6. Nosti-Escanilla MP, Peña AS.
    NF-kB y enfermedad inflamatoria intestinal.
    Rev Esp Enferm Dig
    1998;90(2):113-119.
  7. Palmen MJ, Dieleman LA, Soesatyo M, Pena AS, Meuwissen SGM, Van Rees EP.
    Effects of local budesonide treatment on the cell-mediated immune response in acute and relapsing colitis in rats
    .
    Dig Dis Sci
    1998; 43(11): 2518-2525.
  8. Peña AS.
    Initiation and perpetuation of inflammatory bowel disease: Strategies for targeting the immune system and inflammatory soluble mediator.
    Pediatrika
    1998;18(3):21-28. 
  9. Peña AS.
    Avances en la etiopatogenia de las enfermedades inflamatorias crónicas intestinales
    .
    In
    : Nuevas fronteras en enfermedad inflamatoria intestinal (Ed.: Gassull Duro MA). Barcelona: Prous Science; 1998. p. 5-6.  
  10. Peña AS.
    Inmunogenética y enfermedad inflamatoria intestinal: factores que determinan la evolución y el pronóstico de la enfermedad.
    In: Nuevas fronteras en enfermedad inflamatoria intestinal (Ed.: Gassull Duro MA). Barcelona: Prous Science; 1998. p. 49-54.  
  11. Peña AS.
    Antígenos de Histocompatibilidad y la colitis ulcerosa en España.
    Rev Esp Enferm Dig
    1998;90(4):239-241.
  12. Peña AS.
    Treatment of perianal and fistulising Crohn's disease
    .
    In
    : Curso de Postgraduados. Controversias en Gastroenterología (Eds.: Jiménez M, Giannella, R) Acción Médica, Madrid, 1998, p. 59-70. 
  13. Peña AS.
    Clinical advances in inflammatory bowel disease; are they relevant in understanding the pathogenesis of IBD? (Session III: Pathogenesis)
    In: Consolidating the Advances in IBD (Ed.: Peña AS). Research and Clinical Forums, Wells Medical, 1998;20(3):99-109.
  14. Peña AS.
    Genetics of Inflammatory Bowel Disease. The candidate gene approach: susceptibility versus disease heterogeneity
    .
    Dig Dis
    1998; 16: 356-363.
  15. Peña AS, Nosti-Escanilla MP, Roca M.
    Nuevos agentes terapéuticos en la enfermedad inflamatoria intestinal: perspectivas de futuro reales
    .
    In
    : Controversias en la enfermedad inflamatoria intestinal (Eds.: Hinojosa del Val J, Díaz de Rojas F) Madrid: Acción Médica; 1998. p. 107-114. 
  16. Peña AS, Crusius JBA.
    Food allergy, coeliac disease and chronic inflammatory bowel disease in man
    .
    Vet Q
    1998;20:S49-S52.
  17. Peña AS, Bouma G, Crusius JBA.
    Aetiopathogenic controversies. Genetics of Crohn's disease and ulcerative colitis
    .
    In
    : V International Symposium on Inflammatory Bowel Diseases, Eilat, Israel (Ed.: Rachmilewitz D) Kluwer Academic Publishers; 1998. p. 57-64.  
  18. Peña AS, Crusius JBA.
    Genetics of inflammatory bowel disease: implications for the future
    .
    World J Surg
    1998;22(4):390-393.
  19. Peña AS, Garrote JA, Crusius JBA.
    Advances in the immunogenetics of coeliac disease. Clues for understanding the pathogenesis and disease heterogeneity
    .
    Scand J Gastroenterol
    1998;225:S56-S58.
  20. Pérez-Pérez GI, Peña AS.
    Serología y respuesta inmunitaria humoral, sistémica y local
    .
    In: Infección por Helicobacter pylori en lesiones gastroduodenales. La segunda década (Eds.: Pajares García JM, Correa P, Pérez-Pérez GI) Barcelona: Prous Science; 1998. p. 73-81. 
  21. Ten Dam M, Van de Wal Y, Mearin ML, Kooy Y, Peña AS, Drijfhout JW, Koning F, Van Tol M.
    Anti-a-gliadin antibodies (AGA) in the serum of coeliac children and controls recognize an identical collection of linear epitopes of a-gliadin
    .
    Clin Exp Immunol
    1998;114(2):189-195.
  22. Van de Wal Y, Kooy Y, Van Veelen PA, Peña AS, Mearin LM, Molberg O, Lundin KE, Sollid LM, Mutis T, Benckhuijsen WE, Drijfhout JW, Koning F.
    Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin
    .
    Proc Natl Acad Sci USA
    1998;95(17):10050-10054.
  23. Van de Wal Y, Kooy Y, van Veelen P, Peña AS, Mearin L, Papadopoulos G, Koning F.
    Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity
    .
    J Immunol
    1998;161(4):1585-1588.
  24. Van Doorn LJ, Figueiredo C, Sanna R, Peña AS, Midolo P, Ng EK, Atherton JC, Blaser MJ, Quint WG.
    Expanding allelic diversity of Helicobacter pylori vacA
    .
    J Clin Microbiol
    1998; 36(9): 2597-2603.
  25. Xia B, Crusius JBA, Meuwissen SGM, Peña AS.
    Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.
    World J Gastroenterol
    1998;4(5):446-458. 
  26. Xia B, Cuo HJ, Crusius JBA, Deng CS, Meuwissen SGM, Peña AS.
    In vitro
    production of TNFa, IL-6 and sIL-2R in Chinese patients with ulcerative colitis
    .
    World J Gastroenterol
    1998;4:252-255. 

     
     

1997

back to top of the page

  1. Bouma G, Oudkerk Pool M, Crusius JBA, Hellemans HPR, Meijer BUGA, Kostense PJ, Giphart MJ, Meuwissen SGM, Peña AS.
    Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD)
    .
    Clin Exp Immunol 1997;109(1):175-179.
     
  2. De la Concha EG, Arroyo R, Crusius JBA, Campillo JA, Martin C, Varela de Seijas E, Peña AS, Claveria LE, Fernández Arquero M.
    Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis
    .
    J Neuroimmunol
    1997;80(1-2):172-178.
  3. Dieleman LA, Peña AS, Meuwissen SGM, Van Rees EP.
    Role of animal models for the pathogenesis and treatment of inflammatory bowel disease.
    Scand J Gastroenterol
    1997;223:S99-104.
  4. García Paredes J, López-Navas G, Peña AS.
    Colitis ulcerosa y enfermedad de Crohn: factores inmunogenéticos
    .
    In
    :  XXIV Congreso Nacional de la SEPD Madrid (Eds.: Pérez Piqueras J, Herrerías Gutiérrez JM, Arenas Miravé JI, Díaz-Rubio M): Editorial Libro del Año; 1997. p. 285-290. 
  5. Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, Langermans JA, Breedveld FC, Verweij CL, Van de Gaer L, Dams L, Crusius JBA, García González MA, Van Oosten BW, Polman CH, Peña AS.
    TNF-a promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients
    .
    J Neuroimmunol 1997;72(2):149-153.
  6. Meuwissen SGM, Crusius JBA, Peña AS, Dekker-Saeys AJ, Dijkmans BAC.
    Spondyloarthropathy and idiopathic inflammatory bowel diseases
    .
    Inflamm Bowel Dis
    1997;3:25-37.
     
  7. Peña AS.
    Physiopathological bases in the medical treatment of inflammatory bowel diseases
    .
    Pediatrika
    1997;17(9):64-68. 
  8. Peña AS, García Paredes J.
    Enfermedad Inflamatoria Intestinal Crónica (EIIC)
    .
    In
    :  Inflamación y enfermedad (Eds.: Espinós D, Díaz-Rubio M). Madrid: Editorial Médica Panamericana; 1997. p. 97-126. 
  9. Xia B, Shivananda S, Zhang G-S, Yi J-Y, Crusius JBA, Peña AS.
    Inflammatory Bowel Disease in Hubei province in China. Clinical analysis of patients with inflammatory bowel disease in The Second Hospital of Hubei Medical University.

    China Natl J New Gastroenterol
    1997;3(2):119-120. 
  10. Xia B, Crusius JBA, Zhang GS, Cuo HJ, Deng CS, Meuwissen SGM, Peña AS.
    Relation of polymorphisms of lymphotoxin a and interleukin-1 receptor antagonist genes to secretion of TNFa, sIL-2r and IL-6 in Chinese patients with inflammatory bowel disease.

    Acta Hubei Medical University 1997; 18: 17-21.
  11. Peña AS. Case presentation:Crohn’s disease, newly developed.
    In:IBD – the patient in focus. (Eds:Munkholm P, Peña AS). Research and Clinical Forums, Wells Medical, 1997;19(1); 11-20.
     

     
     

1996

back to top of the page

  1. Bioque G, Bouma G, Crusius JBA, Koutroubakis I, Kostense PJ, Meuwissen SGM, Peña AS.
    Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis
    .
    Eur J Gastroenterol Hepatol
    1996;8(2):105-110.
  2. Bouma G, Crusius JBA, Oudkerk Pool M, Kolkman JJ, Von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SGM, Peña AS.
    Secretion of tumour necrosis factor a and lymphotoxin a in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease.

    Scand J Immunol
    1996;43(4):456-463.
     
  3. Bouma G, Xia B, Crusius JBA, Bioque G, Koutroubakis I, Von Blomberg BM, Meuwissen SGM, Peña AS.
    Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD)
    .
    Clin Exp Immunol
    1996;103(3):391-396.
     
  4. Kolkman JJ, Falke TH, Roos JC, Van Dijk DH, Bannink IM, Den Hollander W, Cuesta MA, Peña AS, Meuwissen SGM.
    Computed tomography and granulocyte scintigraphy in active inflammatory bowel disease. Comparison with endoscopy and operative findings
    .
    Dig Dis Sci
    1996;41(4):641-650.
  5. Koutroubakis I, Manousos ON, Meuwissen SGM, Peña AS.
    Environmental risk factors in inflammatory bowel disease.

    Hepatogastroenterol
    1996;43(8):381-393.
  6. Kuipers EJ, Pals G, Peña AS, Van Uffelen CW, Kok A, Westerveld BD, Meuwissen SGM.
    Helicobacter pylori
    , pepsinogens and gastrin: relationship with age and development of atrophic gastritis.

    Eur J Gastroenterol Hepatol
    1996;8(2):153-156.
  7. Peña AS.
    Avances en el tratamiento de la enfermedad inflamatoria intestinal.

    In
    : XXIII Congreso Nacional de la SEPD; Sevilla (Spain): Prous Science, Barcelona; 1996. p. 33-48. 
  8. Peña AS, Crusius JBA.
    Malignancy, autoimmune disease, survival, and quality of life in coeliac disease
    .
    Pediatrika
    1996;16:406-411. 
  9. Van Zwet AA, Thijs JC, Roosendaal R, Kuipers EJ, Peña S, De Graaff J.
    Practical diagnosis of Helicobacter pylori infection
    .
    Eur J Gastroenterol Hepatol
    1996;8(5):501-507. 
  10. Von Blomberg BME, Mearin ML, Houwen RH, Peña AS.
    Serological assays for diagnosing coeliac disease
    .
    Pediatrika
    1996;16:367-371. 
     
     

1995

back to top of the page

  1. Bioque G, Crusius JBA, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SGM, Peña AS.
    Allelic polymorphism in IL-1b and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease
    .
    Clin Exp Immunol
    1995;102(2):379-383.
  2. Bouma G, Oudkerk Pool M, Scharenberg JG, Kolkman JJ, Von Blomberg BM, Scheper RJ, Meuwissen SGM, Peña AS.
    Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor a and b in patients with inflammatory bowel disease and healthy controls
    .
    Scand J Gastroenterol
    1995;30(11):1095-1100.
  3. Caprilli R, Peña A, Dianzani F, Pallone F, Vernia P.
    Pathogenetic mechanisms of inflammatory bowel disease
    .
    Ital J Gastroenterol
    1995;27(6):313-326. 
  4. Crusius JBA, Peña AS, Van Oosten BW, Bioque G, Garcia A, Dijkstra CD, Polman CH.
    Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis
    .
    Lancet
    1995;346(8980):979-980.
  5. Koutroubakis I, Xia B, Crusius JBA, Bioque G, Bouma G, Meuwissen SGM, Manousos ON, Peña AS.
    Tumor necrosis factor-a polymorphism in inflammatory bowel disease.
    Hell J Gastroenterol
    1995;8(2):132-135.
     
  6. Koutroubakis I, Crusius JBA, Peña AS.
    Immunogenetics of cytokines. Relevance for future research on inflammatory bowel disease.
    Scand J Gastroenterol
    1995;30(12):1139-1146.
  7. Kuipers EJ, Uyterlinde AM, Peña AS, Roosendaal R, Pals G, Nelis GF, Festen HP, Meuwissen SGM.
    Long-term sequelae of Helicobacter pylori gastritis.
    Lancet 1995;345(8964):1525-1528.
  8. Kuipers EJ, Peña AS, Crusius JBA, Defize J, Van der Stoop P, Meuwissen SGM, Pals G.
    Absence of pepsinogen A3 gene expression in the gastric mucosa of patients with gastric cancer.

    J Clin Pathol
    1995;48(4):376-379.
  9. Kuipers EJ, Peña AS, Meuwissen SGM.
    Helicobacter pylori-infectie oorzakelijke factor bij ontstaan carcinoom en lymfoom van de maag; verslag WHO-consensusbespreking
    .
    Ned Tijdschr Geneeskd 1995;139(14):709-712.
  10. Kuipers EJ, Uyterlinde AM, Peña AS, Hazenberg HJ, Bloemena E, Lindeman J, Klinkenberg-Knol EC, Meuwissen SGM.
    Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.
    Am J Gastroenterol
    1995;90(9):1401-1406.
  11. Namavar F, Roosendaal R, Kuipers EJ, De Groot P, Van der Bijl MW, Peña AS, De Graaff J.
    Presence of Helicobacter pylori in the oral cavity, oesophagus, stomach and faeces of patients with gastritis
    .
    Eur J Clin Microbiol Infect Dis
    1995;14(3):234-237.
  12. Oudkerk Pool M, Bouma G, Visser JJ, Kolkman JJ, Tran DD, Meuwissen SGM, Peña AS.
    Serum nitrate levels in ulcerative colitis and Crohn's disease.
    Scand J Gastroenterol 1995;30(8):784-788. 
  13. Oudkerk Pool M, Bouma G, Meuwissen SGM, Von Blomberg BM, Van de Merwe JP, Deville WL, Fonk JC, Peña AS.
    Serological markers to differentiate between ulcerative colitis and Crohn's disease
    .
    J Clin Pathol
    1995;48(4):346-350.
  14. Palmen MJ, Dijkstra CD, Van der Ende MB, Peña AS, Van Rees EP.
    Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats
    .
    Clin Exp Immunol 1995;101(2): 351-356.
  15. Palmen MJ, Dieleman LA, van der Ende MB, Uyterlinde A, Peña AS, Meuwissen SGM, Van Rees EP.
    Non-lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis.
    Clin Exp Immunol
    1995;99(2):226-232. 
  16. Peña AS, Crusius JBA, Koutroubakis I, Bioque G, Bouma G, Pladdet IE, Oudejans CBM, Doekhie FS, Meuwissen SGM.
    Preliminary results on cytokine genes and mucin genes polymorphisms.
    In: Inflammatory Bowel Diseases (Eds.: Tytgat GNJ, Bartelsman JFWM, Van Deventer SJH); Den Haag: Kluwer Academic Publishers; 1995. p. 232-238. 
  17. Roosendaal R, Kuipers EJ, Peña AS, De Graaff J.
    Recovery of Helicobacter pylori from gastric biopsy specimens is not dependent on the transport medium used.

    J Clin Microbiol 1995;33(10):2798-2800. 
  18. Stange EF, Modigliani R, Peña AS, Wood AJ, Feutren G, Smith PR.
    European trial of cyclosporine in chronic active Crohn's disease: a 12-month study.
    The European Study Group. Gastroenterology 1995;109(3):774-782.
  19. Thijs JC, Kuipers EJ, Van Zwet AA, Peña AS, De Graaff J.
    Treatment of Helicobacter pylori infections
    .
    QJM
    1995;88(6):369-389.
  20. Van Rees EP, Soesatyo M, Van der Ende M, Peña AS, Sminia T.
    Non-lymphoid cells in experimental inflammatory bowel disease
    .
    Adv Exp Med Biol
    1995;371(B):1389-1393.
  21. Van Tol EA, Verspaget HW, Peña AS, Lamers CB.
    Detection of cells with NK activity from histologically normal mucosa in relation to disease
    .
    Adv Exp Med Biol
    1995;371(A):313-316. 
  22. Veenendaal RA, Gotz JM, Schroijen V, Kurban F, Bernards AT, Veselic M, Peña AS, Lamers CB.
    Diagnosis of Helicobacter pylori infection by specific gastric mucosal IgA and IgG pylori antibodies.

    J Clin Pathol
    1995;48(11):990-993. 
  23. Xia B, Bouma G, Crusius JBA, Meuwissen SGM, Peña AS.
    Distribution of an NcoI polymorphism in the lymphotoxin a gene in Dutch patients with inflammatory bowel diseases
    .
    Chin Med J
    (Engl) 1995;108(10):739-742.
  24. Peña AS. Autoimmunity in inflammatory bowel disease.
    In:IBD and salicylates-2. (Ed:Modigliani S). Research and Clinical Forums, Wells Medical, 1995;17(1); 153-163.

 

1994

back to top of the page

  1. Kolkman JJ, Ross JC, Falke TH, Peña AS.
    Value of granulocyte scintigraphy in inflammatory bowel disease
    .
    Gut
    1994;35(11):1676-1677.
  2. Kuipers EJ, Peña AS, Meuwissen SGM.
    H. pylori
    and gastric cancer: limitations of retrospective studies
    .
    Gastroenterology
    1994;106(5):1398-1400.
  3. Mulder TP, Van der Sluys Veer A, Verspaget HW, Griffioen G, Peña AS, Janssens AR, Lamers CB.
    Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease
    .
    J Gastroenterol Hepatol
    1994;9(5):472-477.
  4. Oudkerk Pool M, Bouma G, Kolkman JJ, Meuwissen SGM, Von Blomberg BM, Peña AS.
    Value of serological determinations in the differential diagnosis of ulcerative colitis and Crohn's disease, and immunogenetic aspects
    .
    Ned Tijdschr Geneeskd
    1994;138(50): 2483-2487.
  5. Palmen MJ, Van der Ende MB, Peña AS, Van Rees EP.
    Non-lymphoid cells in acute and chronic experimental inflammatory bowel disease
    .
    Adv Exp Med Biol
    1994;355:283-287. 
  6. Peña AS, Crusius JBA, Oudkerk Pool M, Bouma G, Bioque G, Meuwissen SGM.
    The contribution of medical genetics to the understanding of the predisposition to ulcerative colitis and Crohn's disease
    .
    In: Inflammatory Bowel Diseases. New insights into mechanisms of inflammation and challenges in diagnosis and treatment (Eds.: Monteiro E, Tavarela Veloso F) Kluwer Academic Publishers; 1994. p. 75-85. 
  7. Roosendaal R, Kuipers EJ, Van den Brule AJ, Peña AS, Uyterlinde AM, Walboomers JM, Meuwissen SGM, De Graaff J.
    Importance of the fiberoptic endoscope cleaning procedure for detection of Helicobacter pylori in gastric biopsy specimens by PCR
    .
    J Clin Microbiol 1994;32(4):1123-1126.

1993

back to top of the page

  1. Peña AS, Crusius JBA, Oudkerk Pool M, Gracia Casanova M, Pals G, Meuwissen SGM, Giphart MJ.
    Genetics and epidemiology may contribute to understanding the pathogenesis of inflammatory bowel disease - a new approach is now indicated
    Can J Gastroenterol 1993; 7:71-75.
  2. Oudkerk Pool M, Ellerbroek PM, Ridwan BU,Goldschmeding R, von Blomberg BME, Peña AS, Dolman KM, Bril H, Dekker W, Nauta JJ, Gans ROB, Breed H, Meuwissen SGM.
    Serum antineutrophil cytoplasmatic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical and surgical treatment.
    Gut 1993;34:46-50.
  3. Van der Meer BWE, Mearin ML, Peña AS, van Tol MJD, Lamers CBHW, Dooren LJ.
    De klinische waarde van de bepaling van anti-gliadine antilichamen in het serum van kinderen met verdenking van coeliakie.
    Tijdschr Kindergeneeskd 1993:61:7-12
  4. Kuipers EJ, Gracia Casanova M, Peña AS, Pals G, van Kamp G, Kok A, Kurz-Pohlmann E, Pels NFM, Meuwissen SGM.
    Helicobacter pylori serology in patients with gastric carcinoma.
    Scand J Gastroenterol 1993:;28:433-437.
  5. Veenendaal RA, Lichtendahl-Bernards AT, Peña AS, Endtz HPh, van Boven CPA, Lamers CBHW.
    Effect of transport medium an transportation time on culture of Helicobacter pylori from gastri biopsy specimens.
    J Clin Pathol 1993; 46: 561-3.
  6. Kuijpers EJ, Peña AS, van Kamp G, Uyterlinde AM, Pals G, Pels NFM, Kurz-Pohlmann E, Meuwissen SGM.
    Seroconversion for helicobacter pylori.
    Lancet 1993;342:328-331.
  7. Van de Wal Y, van der Sluys Veer A, Verspaget HW, Mulder TPJ, Griffioen G, van Tol EAF, Peña AS, Lamers CBHW.
    Effect of zinc therapy on natural killer cell activity in inflammatory bowel disease.
    Aliment Pharmacol Ther 1993;7:281-286.
  8. Mulder CJ, Mearin ML, Pena AS.
    Clinical and pathological spectrum of coeliac disease
    .
    Gut 1993 Dec;34(12):1740-1
  9. Roosendaal R, Kuipers EJ, van den Brule AJ, Pena AS, Meuwissen SG, Walboomers JM, de Graaff J.
    Detection of Helicobacter pylori DNA by PCR in gastrointestinal equipment
    .
    Lancet 1993 Apr 3;341(8849):900
  10. Tran DD, Visser JJ, Pool MO, Cuesta MA, Hoekman K, Pena AS, Meuwissen SG.
    Enhanced systemic nitric oxide production in inflammatory bowel disease
    .
    Lancet 1993 May 1;341(8853):1150

1992

back to top of the page

  1. Van Tol EAF, Verspaget HC, Peña AS, Kraemer CVE, CBHW Lamers.
    The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria.

    Eur J Immunol 1992;22:23-9.
  2. Bontkes HJ, Veenendaal RA, Peña AS, Goedhard JG, van Duijn W, Meijer JL, and C.B.H.W. Lamers.
    IgG subclass response to Helicobacter pylori in patients with chronic active gastritis and relapsing duodenal ulcer.
    Scand J Gastroenterol 1992;27:129-133.
  3. Veenendaal RA, Biemond I, Peña AS, van Duijn W, Kreuning J, Lamers CBHW.

    Influence of age and Helicobacter pylori infection on serum pepsinogens in healthy blood transfusion donors.
    Gut 1992;33:452-455.

  4. Arndt J-W, van der Sluys Veer A, Block D, Griffioen G, Verspaget HW, Peña AS, Lamers CBHW, Pauwels EKJ.
    A prospective comparison of 99mTC-labeled polyclonal human immunoglobulin and 111In granulocytes for localization of inflammatory bowel disease.
    Acta Radiol 1992;33:140-144.
  5. Sierra R, Muñoz N, Peña AS, Biemond I, van Duijn W, Lamers CBHW, Teuchman S, Hernández S, Correa P.
    Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer.
    Cancer Epidemiol Biomark Prev 1992;1:449-454.

    Cancer Epidemiol Biomark Prev 1992;1:449-454
  6. Rust C, Kooy Y, Peña AS, Mearin ML, Kluin P, Koning F.
    Phenotypical and functional characterization of small intestinal TcRgd+ T cells in coeliac disease.

    Scand J Immunol 1992;35:459-468.
  7. Kneppelhout JC, Chandie Shaw P, Peña AS, Meuwissen SGM.
    Jejuno-ileitis, a subtype of extensive and diffuse Crohn's disease
    .
    J.Clin Nutr Gastroenterol 1992;7:15-21.
  8. Peña AS, Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SGM.
    Epidemiología y clínica de las enfermedades relacionadas con la secreción gástrica.
    Rev Farmacol Clin Exp 1992;NEesp.:161-164.
  9. Janssen M, Dijkmans BAC, Vandenbroucke JP, Duijn v W, Peña AS, Lamers CBHW.
    Decreased level of antibodies against Helicobacter pylori in patients with rheumatoid arthritis receiving intramuscular gold.

    Ann Rheum Dis 1992;51:1036-1038.
  10. Sachar DB, Andrews HA, Farmer RG, Pallone F, Peña AS, Prantera C, Rutgeerts P.
    Proposed classification of patient subgroups in Crohn's disease.

    Working Team Report. Gastroenterol Internat 1992;5:141-154.
  11. Van Tol EAF, Verspaget HC, Peña AS, CBHW Lamers.
    Normal inflammatory bowel disease mucosa conceals alterations in natural killer cell activity.

    Scand J Gastroenterol 1992;27:999-1005.

1991

1. Veenendaal RA, Peña AS, Meijer JL, et al.
Long term serological surveillance after treatment of Helicobacter pylori infection.
Gut 1991;32:1291-4.

2. van Tol EA, Verspaget HW, Peña AS, et al.
Modulatory effects of VIP and related peptides from the gastrointestinal tract on cell mediated cytotoxicity against tumour cells in vitro.
Immunol Invest 1991;20:257-67.

3. Sierra R, Ohshima H, Munoz N, Teuchmann S, Peña, A. S. et al.
Exposure to N-nitrosamines and other risk factors for gastric cancer in Costa Rican children.
IARC Sci Publ 1991:162-7.

4. Schweizer JJ, Mearin ML, Peña AS, et al.
Expression of HLA-DQ antigens in the small-intestinal mucosa of patients with coeliac disease.
Scand J Gastroenterol 1991;26:605-10.

5. Peña AS.
[Crohn's disease in Spain. Don Carlos Marina Fiol, 30 years ago].
Rev Esp Enferm Dig 1991;80:219-20.

6. Mulder TP, Verspaget HW, Janssens AR, de Bruin PA, Peña, A. S. et al.
Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease.
Gut 1991;32:1146-50.

7. Lamers CB, Rieu PN, Veenendaal RA, van Duijn W, Offerhaus GJ, Joosten HJ, Peña AS..
Effect of partial gastrectomy on serum anti-Helicobacter pylori immunoglobulins in peptic ulcer patients.
Dig Dis Sci
1991;36:1697-701.

8. Kluin PM, Rust CJ, Mearin ML, et al.
TCR gamma delta cells: antigen-driven expansion of distinct subsets based on localization and antigen specificity.
Immunol Res 1991;10:313-20.

9. Arndt JW, van der Sluys Veer A, Blok D, et al.
Technetium-99m nanocolloid for the scintigraphic assessment of inflammatory bowel disease in the colon: its value in comparison with indium-111-labelled granulocytes.
Eur J Radiol 1991;12:30-4.

10. Aparicio-Pages MN, Verspaget HW, Peña AS, et al.
Natural killer cell activity in patients with adenocarcinoma in the upper gastrointestinal tract.
J Clin Lab Immunol 1991;35:27-32.

11. Aparicio-Pages MN, Verspaget HW, Peña AS, et al.
Natural killer cell activity in patients with neuroendocrine tumours of the gastrointestinal tract; relation with circulating gastrointestinal hormones.
Neuropeptides 1991;20:1-7.

1990

1.            Peña AS.
Changing patterns of inflammatory bowel diseases.
Scand J Gastroenterol Suppl 1990;172:1-3.

2.            Crama-Bohbouth GE, Peña AS, Arndt JW, et al.
Value of indium-111 tropolonate autologous granulocyte scintigraphy in the assessment of inflammatory bowel disease.
Scand J Gastroenterol Suppl 1990;178:93-8.

3.            Aparicio-Pages MN, Verspaget HW, Hafkenscheid JC, Crama-Bohbouth, GE, Peña AS, et al.
Inhibition of cell mediated cytotoxicity by sulphasalazine: effect of in vivo treatment with 5-aminosalicylic acid and sulphasalazine on in vitro natural killer cell activity.
Gut 1990;31:1030-2.

4.            Aparicio-Pages MN, den Hartog G, Verspaget HW, Peña AS, et al.
Decreased natural killer cell activity in late-onset hypogammaglobulinaemia.
Clin Sci (Lond) 1990;78:133-7.

 

 

1989

1. Aparicio-Pagés NM, Verspaget HW, Peña AS, Lamers CBHW
Impaired local natural killer cell activity in human colorectal carcinomas.
Cancer Immunol. Immunother. 1989;28:301-304.

2. Crama-Bohbouth G, Peña AS, Verspaget HW, van der Zon A, Biemond I, Weterman
Immunological findings in whole and parotid saliva of patients with ulcerative colitis and controls.
Hepato-Gastroenterol.1989;36:185-187.

1987

back to top of the page 

  1. Polanco I, Mearin ML, Larrauri J, Biemond I, Wipkink-bakker A, Peña AS.
    Effect of Gluten Supplementation in Healthy Siblings of Children With Celiac Disease
    .
    Gastroenterology 1987;92:678-81.

 

1983

back to top of the page

    1. Crama-Bohbouth G, Bosman FT, Vermeer BJ, van der Wal AM, Biemond I, Wetermand IT, Peña AS.
        Immunohistological findings in lip biopsy specimens from patients with Crohn's disease and healthy subjects.
        Gut 1983;24:202-205
       
            

  2.  Mulder CJJ, Peña AS, Jansen J, Oosterhuis JA
       Celiac Disease and Geographic (Serpiginous) Choroidopathy With Occurrence of Thrombocytopenic Purpura.
       Arch Intern Med 1983;143:Letter to the Editor p. 842